Cargando…

Correction to: SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma

Detalles Bibliográficos
Autores principales:	Guo, Min, Goudarzi, Kaveh M., Abedi, Shiva, Pieber, Melanie, Sjöberg, Elin, Behnan, Jinan, Zhang, Xing-Mei, Harris, Robert A., Bartek, Jiri, Lindström, Mikael S., Nistér, Monica, Hägerstrand, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363096/ https://www.ncbi.nlm.nih.gov/pubmed/34257430 http://dx.doi.org/10.1038/s41388-021-01929-9

Ejemplares similares

SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma
por: Guo, Min, et al.
Publicado: (2021)

NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape
por: Holmberg Olausson, Karl, et al.
Publicado: (2015)

Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
por: Hägerstrand, Daniel, et al.
Publicado: (2011)

Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2015)

Identification of functionally distinct and interacting cancer cell subpopulations from glioblastoma with intratumoral genetic heterogeneity
por: Guo, Min, et al.
Publicado: (2020)

Role of ribosomal protein mutations in tumor development (Review)
por: GOUDARZI, KAVEH M., et al.
Publicado: (2016)

Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes
por: Keller, Maureen, et al.
Publicado: (2022)

Ultrasonic Surgical Aspirate is a Reliable Source For Culturing Glioblastoma Stem Cells
por: Behnan, Jinan, et al.
Publicado: (2016)

Silencing of Ribosomal Protein S9 Elicits a Multitude of Cellular Responses Inhibiting the Growth of Cancer Cells Subsequent to p53 Activation
por: Lindström, Mikael S., et al.
Publicado: (2010)

Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastoma
por: CHANG, LIANG, et al.
Publicado: (2016)

Expression Levels and Localizations of DVL3 and sFRP3 in Glioblastoma
por: Kafka, Anja, et al.
Publicado: (2017)

Expanding the scope of candidate prognostic marker IGFBP2 in glioblastoma
por: Lindström, Mikael S.
Publicado: (2019)

Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia
por: Ghasemi, Ali, et al.
Publicado: (2015)

DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients
por: Liu, Xinyan, et al.
Publicado: (2019)

The association between Annexin A2 and epithelial cell adhesion molecule in breast cancer cells
por: Al‐Qahtani, Saad Misfer, et al.
Publicado: (2021)

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
por: Garros-Regulez, Laura, et al.
Publicado: (2016)

The landscape of the mesenchymal signature in brain tumours
por: Behnan, Jinan, et al.
Publicado: (2019)

Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
por: Wu, Yonghe, et al.
Publicado: (2020)

The role of dexamethasone in mediating the contradictory effects of Wnt antagonists SFRP2 and SFRP3 on human hair follicle growth
por: Hamida, Ons Ben, et al.
Publicado: (2023)

p53 -Dependent and -Independent Nucleolar Stress Responses
por: Olausson, Karl Holmberg, et al.
Publicado: (2012)

SFRP2 Is Associated with Increased Adiposity and VEGF Expression
por: Crowley, Rachel K., et al.
Publicado: (2016)

CRISPR/Cas9 Deletion of SOX2 Regulatory Region 2 (SRR2) Decreases SOX2 Malignant Activity in Glioblastoma
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2021)

Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
por: Zisi, Asimina, et al.
Publicado: (2022)

Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma
por: Sremac, Maja, et al.
Publicado: (2021)

p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways
por: Lindström, Mikael S., et al.
Publicado: (2022)

Oncogenic activity of SOX1 in glioblastoma
por: Garcia, Idoia, et al.
Publicado: (2017)

Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors
por: Hede, Sanna-Maria, et al.
Publicado: (2011)

Neural network learning defines glioblastoma features to be of neural crest perivascular or radial glia lineages
por: Hu, Yizhou, et al.
Publicado: (2022)

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
por: Kaur, Amanpreet, et al.
Publicado: (2016)

Dopamine signaling: target in glioblastoma
por: Bartek, Jiri, et al.
Publicado: (2014)

Hyperactivated Wnt-β-catenin signaling in the absence of sFRP1 and sFRP5 disrupts trophoblast differentiation through repression of Ascl2
por: Bao, Haili, et al.
Publicado: (2020)

EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines
por: Liu, Yuting, et al.
Publicado: (2020)

SFRP2 and Slug Contribute to Cellular Resistance to Apoptosis in Hypertrophic Scars
por: Chen, Liang, et al.
Publicado: (2012)

The defect of SFRP2 modulates an influx of extracellular calcium in B lymphocytes
por: Tokuda, Yuichi, et al.
Publicado: (2014)

Feasibility of Plasma-Methylated SFRP2 for Early Detection of Gastric Cancer
por: Miao, Jin, et al.
Publicado: (2020)

The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter
por: Liu, Qian, et al.
Publicado: (2019)

Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease
por: Wu, Yu, et al.
Publicado: (2020)

Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells
por: Cox, Jesse L., et al.
Publicado: (2012)

Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
por: Bhuvanalakshmi, Gurubharathi, et al.
Publicado: (2018)

LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma
por: Liu, Boyang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kenblkllvrd27slj5e1337kss4